2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Complications Infections

29.12 - Collagenous Colitis in Immunosuppressed Baboons - an Infectious Origin?

Presenter: David, Cooper, Pittsburgh, United States
Authors: Dons E., Montoya C., Klein E., Echeverri G., Wolf R., IJzermans J., Wagner R., Cooper D.

COLLAGENOUS COLITIS IN IMMUNOSUPPRESSED BABOONS - AN INFECTIOUS ORIGIN?

COMPLICATIONS - INFECTIONS

E.M. Dons1, C. Montoya1, E. Klein2, G.J. Echeverri1, R.F. Wolf3, J.N.M. Ijzermans4, R. Wagner2, D.K.C. Cooper1
1Department Of Surgery, Thomas E. Starzl Transplantation Intitute, University of Pittsburgh, Pittsburgh/UNITED STATES OF AMERICA, 2Division Of Laboratory Animal Resources, University of Pittsburgh, Pittsburgh/PA/UNITED STATES OF AMERICA, 3Comparative Medicine, Oklahoma University Health Sciences Center, Oklahoma/UNITED STATES OF AMERICA, 4General Surgery, Erasmus MC, Rotterdam/NETHERLANDS

Body:
Introduction: Collagenous colitis is a chronic inflammatory bowel disease of unknown etiology, presenting with chronic watery diarrhea. The disease is mainly localized to the colon and rectum, and is characterized by a normal appearance of the mucosa on endoscopy and radiology, but with distinct histopathological changes seen on microscopic examination. Case Reports: We report 4 young baboons (age 7-12 months) that had been receiving immunosuppressive therapy (anti-CD154mAb, 25 mg/kg/week i.v. and mycophenolate mofetil, 50 – 150 mg/kg/2xdaily p.o.) for periods of 4-10 months. All baboons had received an artery patch graft from either another baboon (allograft) or a pig (xenograft) at 3 months of age. All presented identical symptoms within a period of 6 weeks, including weight loss associated with chronic watery diarrhea that was unresponsive to standard antimicrobial treatment. Clinical chemistry evaluations were within normal ranges, and fecal as well as blood cultures were repeatedly negative. One baboon died and one was euthanized for severe dehydration that could not be improved by fluid replacement; at necropsy, both were found to have a collagenous colitis. In the remaining two baboons that had identical clinical features of colitis, immunosuppressive therapy was discontinued and treatment with budesonide was initiated; this orally-administered non-absorbed steroid has efficacy in the terminal ileum and colon. A colonoscopy carried out in one of the two symptomatic infants was inconclusive as biopsies did not include layers deeper than the mucosa. Both baboons recovered and remain well on no medication 12 months later. Conclusion: Collagenous colitis is a chronic inflammatory bowel disease that is fairly common in adult humans, but rare in infants. In humans, it presents mainly in elderly women, and is associated with autoimmune disorders. It is not commonly associated with an immunocompromised state, though it has been reported occasionally in patients with organ transplants. It has been reported only once previously in baboons. The 4 cases reported here strongly suggest that (i) it was associated with the immunocompromised state of the baboons, as 2 non-immunosuppressed age-matched baboons in close proximity did not develop the condition, and (ii) it may have had an infectious origin as all 4 cases developed within a 6 week period of time, even though the ages of the baboons differed significantly, as did the periods of time they had been receiving immunosuppressive therapy.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada